Fosun Pharma Deal History & Licensing Activity
Fosun Pharma is a large biotech headquartered in US. Over the past three years, Fosun Pharma has been involved in 1 licensing and acquisition transaction, with a primary focus on Other (2 deals).
Deals (12mo)
2
Active Trials
0
Top Modality
Other
Focus Area
Neurology
Fosun Pharma Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Fosun Pharma in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| phase 3 Alzheimer's candidate | AriBio | Other | Phase 3 | option | May 13, 2026 |
Fosun Pharma Pipeline Focus
Therapeutic areas and modalities where Fosun Pharma is most active based on deal history and clinical trial data.
See How Your Asset Matches Fosun Pharma's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Neurology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Neurology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for neurology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Fosun Pharma Licensing & Deal Activity
Fosun Pharma is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape. With 1 deal over the past three years, Fosun Pharma ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Fosun Pharma include Neurology (2 deals and trials). In terms of modality, Fosun Pharma has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Fosun Pharma and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Fosun Pharma's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.